Page 16 - Pharma

Zydus to market immunosuppressant drug of Switzerland's Neovii in India

The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplant

Jubilant's lyophilised kit for radiopharmaceuticals receives Australian approval

The company has received TGA's nod for lyophilised kit for the preparation of Technetium 99m Macro-Aggregated Albumin (MAA) injection

BASF to build vitamin A plant in Ludwigshafen

The new plant will increase the company's vitamin A capacity by 1,500 metric tonnes per annum

Intas Pharma acquires Teva's UK and Ireland assets for GBP 603 mn

Acquisition will help Intas to strengthen its presence in European healthcare sector, one of its key overseas markets

Emergent BioSolutions bags $1.6 bn contract for anthrax vaccine in US

The company was awarded the contract by the Biomedical Advanced Research and Development Authority (BARDA) for advanced development & delivery of NuThrax vaccine

AbbVie opens small molecule API facility in Singapore

The facility, which marks AbbVie's first manufacturing presence in Asia, is the first phase of the project to develop a production site in Singapore which will also house a biologics facility

Jubilant receives US FDA approval for Ruby-Fill in heart test

Ruby-Fill, for which the current estimated US market size is $ 76 million, has a potential to grow up to $ 250 million annually in the next five years

Novo Nordisk to layoff 1,000 employees globally

This is one of several actions taken to reduce operating costs as the company faces a challenging competitive environment in 2017, especially in its large US market

US FDA issues thirteen 483 observations for Alkem's Daman facility

Observations were issued to the company following US drug regulator's inspection at its manufacturing facility at Daman from September 20 to September 29, 2016

Zydus ties up with Medicines for Malaria Venture to co-develop antimalarial drug

The Ahmedabad-based pharma major will lead the development of the novel compound, which was discovered by MMV in collaboration with AstraZeneca, India

Non-availability of D-penicillamine disrupts Panacea Biotec's Cilamin capsule supply

The company, which recently released limited quantities of the medicine in the market, is holding talks with Indian and China raw material suppliers to normalise the situation

Systech eyes growth in Indian pharma sector as traceability gains traction

With developed countries enacting stringent serialisation and tracing regulations, the company aims to capitalise on India's booming pharmaceutical market

The hidden truth of medical education: Dr Dharminder Nagar

By setting up more medical colleges in tier II and III cities, one can prevent over-crowding of city hospitals by patients from rural areas

Sanofi to get $ 43.2 mn from US HHS to fund Zika vaccine research

The funds will be used for phase II development and manufacturing of an inactivated Zika vaccine

Cambrex acquires PharmaCore to expand clinical stage API capabilities

The acquisition will enhance Cambrex's portfolio of small molecule API services and complements its existing large scale, multi-purpose manufacturing facilities in the US and Europe

PerkinElmer to realign business into two segments

Prahlad Singh to lead the diagnostics business, while Jim Corbett to head the discovery & analytical solutions business

Kilitch Drugs allotted land in Ethiopia to set up production facility

The company has been looking to expand its presence in Africa with plans to set up manufacturing facilities in Ethiopia and Burkina Faso primarily for nutraceuticals

Pfizer completes sale of 4 products to Piramal Enterprises

In May 2016, the US-based pharma major entered into an agreement with Piramal Enterprises to sell its four products for a total consideration of Rs 110 crores

Suven Life secures patents for CNS drug in India and Japan

These patents are valid through 2026 and 2032 in India and Japan, respectively

Merck to invest Euro 50 mn in German pharma packaging unit

The unit will focus on Merck's brands Glucophage, Concor and Euthyrox to meet increasing patient needs in the areas of diabetes, cardiovascular diseases and thyroid disorders